M&A professional with over a decade working in as an investment banker, I'm frequently seeing that what we do is often seen as some obscure science by many clients. Based on this assumption, I decided to start this website as a resource about the M&A world available to all so that those who wish to learn more about Mergers & Acquisitions can do so.
Unicorns and Q3 M&A sector Update

Unicorns and Q3 M&A sector Update

On

The end of a quarter usually means, for those of us in the deal space, receiving various emails updating us on global M&A activities. Today was no exception with, notably, Thomson Reuters and Merrill DataSite reps hitting my inbox with links to…

Endo International gets green light to buy Par Pharmaceuticals with only a couple of tweaks

Endo International gets green light to buy Par Pharmaceuticals with only a couple of tweaks

On

I love the Pharma space, M&A-wise. It’s a huge market with many players and with a bunch of firms thriving in executing roll-up acquisition strategies. The other reason why I love the Pharma space is for the readily available information in the space….

Meanwhile, in Lala Land

Meanwhile, in Lala Land

On

Now that we’ve talked about alcohol, let’s talk about the other French teens favorite (and US teens too), marijuana. As you most certainly know, certain States in the US have legalized marijuana for medical use, allowing users to move from their street dealers to…